BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10461542)

  • 1. Damage and repair of nerve cell DNA in toxic stress.
    Kisby GE; Kabel H; Hugon J; Spencer P
    Drug Metab Rev; 1999 Aug; 31(3):589-618. PubMed ID: 10461542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner.
    Kisby GE; Fry RC; Lasarev MR; Bammler TK; Beyer RP; Churchwell M; Doerge DR; Meira LB; Palmer VS; Ramos-Crawford AL; Ren X; Sullivan RC; Kavanagh TJ; Samson LD; Zarbl H; Spencer PS
    PLoS One; 2011; 6(6):e20911. PubMed ID: 21731631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycad toxin-induced damage of rodent and human pancreatic beta-cells.
    Eizirik DL; Kisby GE
    Biochem Pharmacol; 1995 Jul; 50(3):355-65. PubMed ID: 7646537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity.
    Esclaire F; Kisby G; Spencer P; Milne J; Lesort M; Hugon J
    Exp Neurol; 1999 Jan; 155(1):11-21. PubMed ID: 9918700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Western Pacific ALS-PDC: Evidence implicating cycad genotoxins.
    Spencer PS; Palmer VS; Kisby GE
    J Neurol Sci; 2020 Dec; 419():117185. PubMed ID: 33190068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS/PDC.
    Spencer PS
    J Neurol Sci; 2022 Feb; 433():120021. PubMed ID: 34635325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?
    Kisby G; Palmer V; Lasarev M; Fry R; Iordanov M; Magun E; Samson L; Spencer P
    Commun Integr Biol; 2011 Nov; 4(6):731-4. PubMed ID: 22446540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?
    Kisby GE; Spencer PS
    Int J Environ Res Public Health; 2011 Oct; 8(10):3889-921. PubMed ID: 22073019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.
    Kisby GE; Spencer PS
    Front Neurosci; 2021; 15():752153. PubMed ID: 34924930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair modulates the vulnerability of the developing brain to alkylating agents.
    Kisby GE; Olivas A; Park T; Churchwell M; Doerge D; Samson LD; Gerson SL; Turker MS
    DNA Repair (Amst); 2009 Mar; 8(3):400-12. PubMed ID: 19162564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions.
    Hugon J; Esclaire F; Lesort M; Kisby G; Spencer P
    Drug Metab Rev; 1999 Aug; 31(3):635-47. PubMed ID: 10461544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?
    Spencer P; Fry RC; Kisby GE
    Front Genet; 2012; 3():192. PubMed ID: 23060898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular networks perturbed in a developmental animal model of brain injury.
    Kisby GE; Standley M; Lu X; O'Malley J; Lin B; Muniz J; Luo NL; Pattee P; Back SA; Nagalla SR
    Neurobiol Dis; 2005; 19(1-2):108-18. PubMed ID: 15837566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC.
    Spencer PS
    Front Neurol; 2019; 10():754. PubMed ID: 31417480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-latency neurodegenerative disease in the western Pacific.
    Spencer PS; Kisby GE; Ludolph AC
    Geriatrics; 1991 Aug; 46 Suppl 1():37-42. PubMed ID: 1894143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region.
    Spencer PS; Kisby GE; Ludolph AC
    Neurology; 1991 May; 41(5 Suppl 2):62-6; discussion 66-8. PubMed ID: 2041595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum.
    Kisby GE; Standley M; Park T; Olivas A; Fei S; Jacob T; Reddy A; Lu X; Pattee P; Nagalla SR
    J Proteome Res; 2006 Oct; 5(10):2656-65. PubMed ID: 17022636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of brain maldevelopment induced by cycad plant genotoxins.
    Kisby GE; Moore H; Spencer PS
    Birth Defects Res C Embryo Today; 2013 Dec; 99(4):247-55. PubMed ID: 24339036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are age-related neurodegenerative diseases linked with various types of magnesium depletion?
    Durlach J; Bac P; Durlach V; Durlach A; Bara M; Guiet-Bara A
    Magnes Res; 1997 Dec; 10(4):339-53. PubMed ID: 9513930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: putative mutagens and carcinogens in foods. V. Cycad azoxyglycosides.
    Hoffmann GR; Morgan RW
    Environ Mutagen; 1984; 6(1):103-16. PubMed ID: 6363050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.